SMMT - Summit Therapeutics Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$23.65
DETAILS
HIGH:
$38.00
LOW:
$11.90
MEDIAN:
$19.50
CONSENSUS:
$23.65
UPSIDE:
72.25%
AlphaVal
Deterministic, archetype-aware fair value
AlphaVal Unavailable
AlphaVal: SMMT has had negative net income and negative EPS in all 5 available fiscal year(s). Quality gate: persistently unprofitable companies are excluded.